Literature DB >> 21864234

Cancer nanotechnology: emerging role of gold nanoconjugates.

Rachel A Kudgus1, Resham Bhattacharya, Priyabrata Mukherjee.   

Abstract

Over the last few decades, the study of nanotechnology has grown exponentially. Nanotechnology bridges science, engineering and technology; it continues to expand in definition as well as practice. One sub-set of nanotechnology is bionanotechnology, this will be the focus of this review. Currently, bionanotechnology is being studied and exploited for utility within medicinal imaging, diagnosis and therapy in regard to cancer. Cancer is a world-wide health problem and the implication rate as well as the death rate increase year to year. However promising work is being done with gold nanoparticles for detection, diagnosis and targeted drug delivery therapy. Gold nanoparticles can be synthesized in various shapes and sizes, which directly correlates to the color; they can also be manipulated to carry various antibody, protein, plasmid, DNA or small molecule drug. Herein we summarize some of the very influential research being done in the field of Cancer Nanotechnology with an emphasis on gold nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864234      PMCID: PMC4684088          DOI: 10.2174/187152011797927652

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  75 in total

Review 1.  The present and future of nanotechnology in human health care.

Authors:  S K Sahoo; S Parveen; J J Panda
Journal:  Nanomedicine       Date:  2007-03       Impact factor: 5.307

Review 2.  Nanotechnology and cancer.

Authors:  James R Heath; Mark E Davis
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

3.  Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.

Authors:  Sanjib Bhattacharyya; Resham Bhattacharya; Steven Curley; Mark A McNiven; Priyabrata Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 4.  Exploiting the enhanced permeability and retention effect for tumor targeting.

Authors:  Arun K Iyer; Greish Khaled; Jun Fang; Hiroshi Maeda
Journal:  Drug Discov Today       Date:  2006-09       Impact factor: 7.851

Review 5.  Gene therapy of pituitary diseases.

Authors:  Eun Jig Lee; J Larry Jameson
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

6.  Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay.

Authors:  Wentong Lu; Sri Ranjini Arumugam; Dulal Senapati; Anant K Singh; Tahir Arbneshi; Sadia Afrin Khan; Hongtao Yu; Paresh Chandra Ray
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

Review 7.  Targeted therapies for cancer 2004.

Authors:  Jeffrey S Ross; David P Schenkein; Robert Pietrusko; Mark Rolfe; Gerald P Linette; James Stec; Nancy E Stagliano; Geoffrey S Ginsburg; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Journal:  Am J Clin Pathol       Date:  2004-10       Impact factor: 2.493

8.  Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.

Authors:  S S Dharap; B Qiu; G C Williams; P Sinko; S Stein; T Minko
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

View more
  8 in total

1.  Folate-Gold-Bilirubin Nanoconjugate Induces Apoptotic Death in Multidrug-Resistant Oral Carcinoma Cells.

Authors:  Pierson Rathinaraj; Ganesan Muthusamy; Nagarajan Rajendra Prasad; Srithar Gunaseelan; Boeun Kim; Suhang Zhu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

Review 2.  Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer.

Authors:  Tobeka Naki; Blessing A Aderibigbe
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

3.  Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy.

Authors:  Jianliang Shen; Han-Cheon Kim; Chaofeng Mu; Emanuela Gentile; Junhua Mai; Joy Wolfram; Liang-nian Ji; Mauro Ferrari; Zong-wan Mao; Haifa Shen
Journal:  Adv Healthc Mater       Date:  2014-04-01       Impact factor: 9.933

4.  Small-angle X-ray scattering method to characterize molecular interactions: Proof of concept.

Authors:  Nicholas Allec; Mina Choi; Nikhil Yesupriya; Brian Szychowski; Michael R White; Maricel G Kann; Elsa D Garcin; Marie-Christine Daniel; Aldo Badano
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

5.  Development and characterization of functionalized glyco thiolate capped gold nanoparticles for biological applications.

Authors:  Christian K Adokoh; Frankline K Keter; Henok H Kinfe; Robert Tshikhudo; James Darkwa
Journal:  RSC Med Chem       Date:  2020-01-28

6.  Formation of nano-bio-complex as nanomaterials dispersed in a biological solution for understanding nanobiological interactions.

Authors:  Mingsheng Xu; Jie Li; Hideo Iwai; Qingsong Mei; Daisuke Fujita; Huanxing Su; Hongzheng Chen; Nobutaka Hanagata
Journal:  Sci Rep       Date:  2012-05-14       Impact factor: 4.379

7.  Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.

Authors:  Rachel A Kudgus; Annamaria Szabolcs; Jameel Ahmad Khan; Chad A Walden; Joel M Reid; J David Robertson; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

8.  Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.

Authors:  Rachel A Kudgus; Chad A Walden; Renee M McGovern; Joel M Reid; J David Robertson; Priyabrata Mukherjee
Journal:  Sci Rep       Date:  2014-07-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.